Early endosomal antigen 1 (EEA1) was significantly increased in the human cerebrospinal fluid from AD patients compared with neurological controls, and EEA1 levels correspond to the increased total-tau levels (Armstrong et al., 2014). This evidence concerns the gene MAPT and Alzheimer disease.